Quarterly Call Option Transactions in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during . The information is specifically focused on institutions that hold call options of NEUROCRINE BIOSCIENCES INC.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 89,000 | 34,902 | 123,902 | 118,400 | 20,000 | 138,400 | -14,498 | |
| Q4 2021 | 89,400 | 58,700 | 148,100 | 7,500 | 150,000 | 157,500 | -9,400 | |
| Q1 2022 | 76,200 | 436,400 | 512,600 | 96,500 | 0 | 96,500 | 416,100 | |
| Q2 2022 | 105,000 | 1,300 | 106,300 | 65,400 | 12,800 | 78,200 | 28,100 | |
| Q3 2022 | 43,700 | 0 | 43,700 | 113,300 | 0 | 113,300 | -69,600 | |
| Q4 2022 | 17,800 | 7,100 | 24,900 | 31,800 | 0 | 31,800 | -6,900 | |
| Q1 2023 | 17,900 | 30,000 | 47,900 | 22,700 | 0 | 22,700 | 25,200 | |
| Q2 2023 | 143,400 | 89,400 | 232,800 | — | 232,800 | |||
| Q3 2023 | 96,700 | 45,100 | 141,800 | — | 141,800 | |||
| Q4 2023 | 700 | 166,400 | 167,100 | 65,000 | 0 | 65,000 | 102,100 | |
| Q1 2024 | 42,700 | 189,600 | 232,300 | 500 | 0 | 500 | 231,800 | |
| Q2 2024 | 52,100 | 230,600 | 282,700 | 56,500 | 0 | 56,500 | 226,200 | |
| Q3 2024 | 65,000 | 222,000 | 287,000 | 112,000 | 0 | 112,000 | 175,000 | |